You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NEO-201

Showing 1 - 25 of 857
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer Trial run by the (NEO-201 in combination

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • NEO-201 in combination with pembrolizumab
  • Bethesda, Maryland
    National Cancer Institute
Apr 1, 2022

Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan,

Recruiting
  • Liver Metastasis Colon Cancer
  • Synchronous Neoplasm
  • Neo-adjuvant Chemotherapy FOLFOXIRI Regimen
  • synchronous resection surgery
  • Ho Chi Minh City, Vietnam
    Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
May 5, 2022

Vascular Aneurysm Trial in Wien, Essen (Open repair)

Recruiting
  • Vascular Aneurysm
  • Open repair
  • Wien, Austria
  • +1 more
May 18, 2022

Rokitansky Kuster Hauser Syndrome, Vaginal Tumors, Gender Incongruence Trial in Amsterdam (Laparoscopic pedicled single flap

Recruiting
  • Rokitansky Kuster Hauser Syndrome
  • +4 more
  • Laparoscopic pedicled single flap peritoneum vaginoplasty
  • Amsterdam, Zuid-Holland, Netherlands
    Amsterdam University Medical Center
Jun 28, 2023

Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

Completed
  • Recurrent Neuroendocrine Tumor
  • Metastatic Neuroendocrine Tumor
  • Cleveland, Ohio
    Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Growth Hormone Deficiency Trial (LUM-201)

Not yet recruiting
  • Growth Hormone Deficiency
  • (no location specified)
Apr 5, 2023

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Portland, Oregon
  • +1 more
Jan 12, 2023

Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning

Recruiting
  • Idiopathic Inflammatory Myopathy
  • +3 more
  • CAB-201 following preconditioning with fludarabine and cyclophosphamide
  • Orange, California
    University of California Irvine
Nov 30, 2023

Growth Hormone Deficiency Trial in Worldwide (LUM-201, rhGH Norditropin® pen (34 µg/kg))

Recruiting
  • Growth Hormone Deficiency
  • LUM-201
  • rhGH Norditropin® pen (34 µg/kg)
  • Birmingham, Alabama
  • +52 more
Jan 30, 2023

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • CABA-201
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 7, 2023

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Early HER2-negative High-risk Breast Cancer and BRCA1/2

Not yet recruiting
  • Breast Cancer
    • Arkhangelsk, Russian Federation
    • +19 more
    Jul 3, 2023

    Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)

    Recruiting
    • Uveal Melanoma
    • Metastatic
    • 4.7 microCi 225Ac-MTI-201
    • +11 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 9, 2022

    Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Advanced Ovarian Cancer
    • AST-201
    • +4 more
    • Seattle, Washington
      University of Washington
    Mar 20, 2023

    Solid Tumor Trial in Wuhan (Neo-T, Cyclophosphamide, Fludarabine)

    Recruiting
    • Solid Tumor
    • Neo-T
    • +3 more
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Mar 23, 2023

    Solid Tumor Trial in Shanghai (Neo-T, Cyclophosphamide, Fludarabine)

    Recruiting
    • Solid Tumor
    • Neo-T
    • +3 more
    • Shanghai, China
    • +1 more
    Mar 23, 2023

    Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury

    Not yet recruiting
    • Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
    • IncobotulinumtoxinA
    • Placebo
    • (no location specified)
    Oct 13, 2023

    Sequent Extended Study

    Not yet recruiting
    • Coronary Artery Disease
    • Ischemic Heart Disease
    • Sequent Please Neo
    • (no location specified)
    Mar 26, 2023

    Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • NXC-201 CAR-T
    • Sacramento, California
      University of California Davis Medical Center
    Oct 19, 2023

    Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,

    Not yet recruiting
    • Recurrent Glioblastoma
    • Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
    • +2 more
    • Brussels, Belgium
      UZ Brussel
    Oct 23, 2023

    Chronic Low-back Pain, Degenerative Disc Disease Trial in Miami (CELZ-201-DDT, Placebo)

    Not yet recruiting
    • Chronic Low-back Pain
    • Degenerative Disc Disease
    • Miami, Florida
      University of Miami
    Sep 25, 2023

    X-linked Retinoschisis Trial (ATSN-201)

    Not yet recruiting
    • X-linked Retinoschisis
    • ATSN-201
    • (no location specified)
    May 26, 2023

    Platysma Prominence Trial in United States (NT 201, NT 201 Placebo)

    Recruiting
    • Platysma Prominence
    • NT 201
    • NT 201 Placebo
    • Washington, District of Columbia
    • +3 more
    Mar 23, 2023

    Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)

    Recruiting
    • Esophageal Cancer
    • +3 more
    • Neoadjuvant immunochemotherapy
    • Zhengzhou, Henan, China
      Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
    Oct 2, 2022